Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Biomarker Targeted Stimulation in Epilepsy

NCT06424977 is registered in ClinicalTrials.gov with Cadence Neuroscience as lead sponsor.

NCT NCT06424977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06424977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Biomarker Targeted Stimulation in Epilepsy
Lead sponsor
Cadence Neuroscience
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
February 14, 2030
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy